Objective: The aim of the study is to identify whether anxiety disorders (AD) are more prevalent in patients with bipolar disorders (BP) who have a co-occurring diagnosis of substance use disorders (SUD) than it is among patients with BP who do not have SUD, and describe the outcomes of treatment when AD are recognized and treated in those patients with a BP, SUD and AD disorders triad. Design: The design is a retrospective chart review. Population, Sample, Setting, Years: The population is the patients from a Bipolar Disorder Research Clinic in Texas(n=293)and the sample is patients who had a completed Strctured Clinical Interview for the DSM-IV (SCID)during the years 1996-2002. Variables: The variables include demographic data; socioeconomic data; Axis I diagnoses and duration, course, severity, and hospitalizations; Global Assessment of Functioning (GAF); Clinical Global Impression scores(CGI); adherence to medications; documentation of anxiety treatment and follow-up. Methods:The chart review will be done using a data collection form for data entry with number assigned for each chart.The SCID, CGI and GAF have adequate reliability and validity. Findings: The findings will be reported using descriptive statistics and differences in prevalence of diagnoses and outcomes of those treated for AD will be evaluated using analysis of variance. Conclusions: The conclusions will be reported in terms of significance of results and relevance to diagnosis and treatment. Implications: The implications for diagnosing and treatment of AD along with BP and SUD, based on results, will be presented.
Back to Posters
Back to 14th International Nursing Research Congress
Sigma Theta Tau International
10-12 July 2003